Forskolin binds directly to adenylate cyclase, catalyzing an increase in the levels of cAMP, a pivotal second messenger within the cell. This surge in cAMP triggers the activation of PKA, an enzyme that can phosphorylate a range of substrates, including proteins similar to FLJ46082. In this manner, Forskolin's effect is established through a classic signaling cascade that culminates in protein activation.
Conversely, inhibitors like H-89, despite their primary role in suppressing PKA activity, can instigate a cellular feedback loop that indirectly activates alternative pathways leading to the activation of proteins paralleling FLJ46082. Genistein, by impeding protein tyrosine kinases, precipitates a shift in phosphorylation balance, which can cascade down to affect the activation status of a variety of proteins, potentially including FLJ46082. Chemical agents such as LY294002 and PD98059, known for their inhibitory action on the PI3K/Akt and MEK/ERK pathways respectively, exert their effects by disrupting the normal phosphorylation of proteins within these pathways. This disruption can lead to an altered functional state of proteins engaged in these signaling cascades, thereby indirectly influencing the activation of FLJ46082.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
PKA inhibitor that can upregulate compensatory pathways, leading to alternate protein activation routes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits protein tyrosine kinases, possibly altering phosphorylation states and affecting protein activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Inhibits a broad range of protein kinases, potentially modifying phosphorylation patterns and activity of signaling proteins. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, affecting PI3K/Akt pathway and altering the activity of proteins in this signaling route. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK1/2, altering the MAPK/ERK pathway and possibly the activity of related proteins. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, affecting the p38 MAPK signaling pathway and the activity of associated proteins. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially altering the activity of proteins regulated by the JNK signaling pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, potentially affecting proteins involved in the MAPK/ERK signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, affecting the mTOR signaling pathway and the activity of connected proteins. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits CaMKII, which can affect calcium/calmodulin-dependent processes and the activity of related proteins. | ||||||